Lixte Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LIXT and other ETFs, options, and stocks.About LIXT
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets.
CEOGeordan G. Pursglove
CEOGeordan G. Pursglove
Employees2
Employees2
HeadquartersBoca Raton, Florida
HeadquartersBoca Raton, Florida
Founded2005
Founded2005
Employees2
Employees2
LIXT Key Statistics
Market cap30.39M
Market cap30.39M
Price-Earnings ratio-3.27
Price-Earnings ratio-3.27
Dividend yield—
Dividend yield—
Average volume74.17K
Average volume74.17K
High today$3.92
High today$3.92
Low today$3.75
Low today$3.75
Open price$3.90
Open price$3.90
Volume79.06K
Volume79.06K
52 Week high$6.26
52 Week high$6.26
52 Week low$0.64
52 Week low$0.64
Stock Snapshot
With a market cap of 30.39M, Lixte Biotechnology(LIXT) trades at $3.86. The stock has a price-to-earnings ratio of -3.27.
During the trading session on 2026-01-04, Lixte Biotechnology(LIXT) shares reached a daily high of $3.92 and a low of $3.75. At a current price of $3.86, the stock is +2.9% higher than the low and still -1.5% under the high.
Trading volume for Lixte Biotechnology(LIXT) stock has reached 79.06K, versus its average volume of 74.17K.
The stock's 52-week range extends from a low of $0.64 to a high of $6.26.
The stock's 52-week range extends from a low of $0.64 to a high of $6.26.
People also own
Based on the portfolios of people who own LIXT. This list is generated using Robinhood data, and it’s not a recommendation.